Complex structures continue to pose significant challenges for comprehensive characterization of innovative therapeutics. Join this webinar to learn how to utilize advanced mass spectrometry ...
A new HIC–MS method using ammonium tartrate improves ADC characterization, enabling efficient drug-to-antibody ratio analysis without complex workflows. A proteomics workflow combining laser ablation ...
Levi Garraway, Roche's chief medical officer and head of global product development. Roche has built the evidence for its oral BTK inhibitor fenebrutinib in multiple sclerosis (MS) with two phase 3 ...